Piedmont Henry Hospital

The Henry Medical Center is accredited by the Commission on Cancer of the American College of Surgeons as a Community Hospital Cancer Program. The center is also accredited by the American College of Radiology (ACR). The Henry Medical Center’s cancer program is comprised of medical oncologists, surgeons and radiation oncologists. The physician staff at the radiation oncology services have interest and expertise in the treatment of prostate, breast, gynecologic and head/neck cancers. The center features the following technology : Elekta Synergy which is a linear accelerator for the delivery of radiation therapy for the treatment of cancer; the Philips Pinnacle treatment planning computer that allows treatment plan customization; and electronic medical records.

Treatment Sites in Georgia

Clinical Trials in Georgia

A Phase 1 Multicenter, Open-label, Dose-escalation and Dose-expansion Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Antitumor Activity of MEDI9447 Alone and in Combination With MEDI4736 in Adult Subjects With Select Advanced Solid Tumors
Cancer Type: Unknown Primary

A Phase Ib/II Clinical Study of BBI608 in Combination With Sorafenib, or BBI503 in Combination With Sorafenib in Adult Patients With Hepatocellular Carcinoma
Cancer Type: Liver Cancer
Study Coordinator: Ann Johnston - 678-298-3235

A Phase III Study of BBI-608 in Combination With 5-Fluorouracil, Leucovorin, Irinotecan (FOLFIRI) in Adult Patients With Previously Treated Metastatic Colorectal Cancer (CRC).
Cancer Type: Colon/Rectal Cancer

A Randomized Multicenter Pivotal Study of CDX-011 (CR011-vcMMAE)in Patients With Metastatic, GPNMB Over-Expressing, Triple Negative Breast Cancer. (The METRIC Study)
Cancer Type: Breast Cancer
Study Coordinator: Ann Johnston - 678-298-3235

A Randomized Phase II Study Comparing Bipolar Androgen Therapy vs. Enzalutamide in Asymptomatic Men With Castration Resistant Metastatic Prostate Cancer
Cancer Type: Prostate Cancer
Study Coordinator: Ann Johnston - 678-298-3235

A Randomized, Open-Label, Multicenter Study of Eribulin Mesylate in Combination with PEGylated Recombinant Human Hyaluronidase (PEGPH20) versus Eribulin Mesylate Alone in Subjects with Human Epidermal Growth Factor Receptor 2 (HER2)-Negative, High-Hyaluronan (HA) Metastatic Breast Cancer
Cancer Type: Breast Cancer

An Open-Label, Randomized Phase 3 Trial of Combinations of Nivolumab, Elotuzumab, Pomalidomide and Dexamethasone in Relapsed and Refractory Multiple Myeloma- CheckMate 602: CHECKpoint Pathway and nivoluMAb Clinical Trial Evaluation 602
Cancer Type: Multiple Myeloma
Study Coordinator: Ann Johnston - 678-298-3235

Randomized Blinded Phase III Assessment of Second or Third-Line Chemotherapy With Docetaxel + Plinabulin Compared to Docetaxel + Placebo in Patients With Advanced Non-Small Cell Lung Cancer and With at Least One Measurable Lung Lesion
Cancer Type: Lung Cancer